249 related articles for article (PubMed ID: 36553667)
1. Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer.
Zhang X; Zeng J; Wang J; Yang Z; Gao S; Liu H; Li G; Zhang X; Gu Y; Pang D
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553667
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract][Full Text] [Related]
3. Profile analysis of N4-acetylcytidine (ac4C) on mRNA of human lung adenocarcinoma and paired adjacent non-tumor tissues.
Shang X; Peng Y; Wang Y; Feng Z; Li M; Peng Z; Ren W
Biochim Biophys Acta Gen Subj; 2023 Dec; 1867(12):130498. PubMed ID: 37890598
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Fan CN; Ma L; Liu N
J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
[TBL] [Abstract][Full Text] [Related]
5. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression.
Wang G; Zhang M; Zhang Y; Xie Y; Zou J; Zhong J; Zheng Z; Zhou X; Zheng Y; Chen B; Liu C
Clin Transl Med; 2022 May; 12(5):e738. PubMed ID: 35522942
[TBL] [Abstract][Full Text] [Related]
6. NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells.
Dalhat MH; Mohammed MRS; Alkhatabi HA; Rehan M; Ahmad A; Choudhry H; Khan MI
Clin Transl Med; 2022 Sep; 12(9):e1045. PubMed ID: 36149760
[TBL] [Abstract][Full Text] [Related]
7. Immunoprecipitation and Sequencing of Acetylated RNA.
Arango D; Sturgill D; Oberdoerffer S
Bio Protoc; 2019 Jun; 9(12):e3278. PubMed ID: 33654795
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of Long Non-Coding RNAs N4-Acetylcytidine in Alzheimer's Disease Mice Model Using High-Throughput Sequencing.
Ma Y; Li W; Fan C; Wang Y; Jiang H; Yang W
J Alzheimers Dis; 2022; 90(4):1659-1675. PubMed ID: 36314201
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA landscape in triple-negative breast cancer.
Zhang W; Guan X; Tang J
Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471
[TBL] [Abstract][Full Text] [Related]
10. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
Wu J; Cai Y; Zhao G; Li M
J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
[TBL] [Abstract][Full Text] [Related]
11. NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression.
Long Y; Ren Y; Wei Q; Mobet Y; Liu Y; Zhao H; Liu T; Cheng L; Yi P
Int J Med Sci; 2023; 20(8):1079-1090. PubMed ID: 37484809
[TBL] [Abstract][Full Text] [Related]
12. Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer.
Le K; Guo H; Zhang Q; Huang X; Xu M; Huang Z; Yi P
Sci Rep; 2019 Oct; 9(1):15122. PubMed ID: 31641220
[TBL] [Abstract][Full Text] [Related]
13. ac4C acetylation regulates mRNA stability and translation efficiency in osteosarcoma.
Zhang W; Gao J; Fan L; Wang J; He B; Wang Y; Zhang X; Mao H
Heliyon; 2023 Jun; 9(6):e17103. PubMed ID: 37484432
[TBL] [Abstract][Full Text] [Related]
14. N-acetyltransferase 10 regulates alphavirus replication via N4-acetylcytidine (ac4C) modification of the lymphocyte antigen six family member E (LY6E) mRNA.
Dang Y; Li J; Li Y; Wang Y; Zhao Y; Zhao N; Li W; Zhang H; Ye C; Ma H; Zhang L; Liu H; Dong Y; Yao M; Lei Y; Xu Z; Zhang F; Ye W
J Virol; 2024 Jan; 98(1):e0135023. PubMed ID: 38169284
[TBL] [Abstract][Full Text] [Related]
15. Acetylation of Cytidine in mRNA Promotes Translation Efficiency.
Arango D; Sturgill D; Alhusaini N; Dillman AA; Sweet TJ; Hanson G; Hosogane M; Sinclair WR; Nanan KK; Mandler MD; Fox SD; Zengeya TT; Andresson T; Meier JL; Coller J; Oberdoerffer S
Cell; 2018 Dec; 175(7):1872-1886.e24. PubMed ID: 30449621
[TBL] [Abstract][Full Text] [Related]
16. Four-lncRNA immune prognostic signature for triple-negative breast cancer Running title: Immune lncRNAs predict prognosis of TNBC.
Li YX; Wang SM; Li CQ
Math Biosci Eng; 2021 May; 18(4):3939-3956. PubMed ID: 34198419
[TBL] [Abstract][Full Text] [Related]
17. NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression.
Zhao CC; Sun X; Chen J; Geng BD
Thorac Cancer; 2024 Apr; 15(10):820-829. PubMed ID: 38409918
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of RNA acetylation modification ac4C in diseases: Current advances and future challenges.
Luo J; Cao J; Chen C; Xie H
Biochem Pharmacol; 2023 Jul; 213():115628. PubMed ID: 37247745
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel long non-coding RNAs in triple-negative breast cancer.
Shen X; Xie B; Ma Z; Yu W; Wang W; Xu D; Yan X; Chen B; Yu L; Li J; Chen X; Ding K; Cao F
Oncotarget; 2015 Aug; 6(25):21730-9. PubMed ID: 26078338
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis.
Zhang S; Ma F; Xie X; Shen Y
Medicine (Baltimore); 2020 Sep; 99(37):e21861. PubMed ID: 32925722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
